Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.243.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.243.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.450ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.450ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.450ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.450NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.130ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.130ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.130ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.130NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.444ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.444ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.444ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.444NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-2586.25US
AW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.268ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.268ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.268ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.268NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.344ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.344ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.344ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.344NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.103ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.103ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.103ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.103NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.485ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.485ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.485ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.485NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.119ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.119ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.119NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.276ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.276ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.276ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.276NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.111ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.111ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used